Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

25.960
-0.340-1.29%
Volume:832.60K
Turnover:21.44M
Market Cap:9.97B
PE:-4.28
High:26.180
Open:26.140
Low:25.080
Close:26.300
52wk High:52.900
52wk Low:19.600
Shares:384.00M
HK Float Shares:352.00M
Volume Ratio:1.00
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-6.070
ROE:--
ROA:-12.49%
PB:4.70
PE(LYR):-4.28
PS:65.50

Loading ...

GenFleet Therapeutics Executes HKD 1.96 Million Share Buyback, Lifts Treasury Stock to 191,000 Shares

Bulletin Express
·
Yesterday

Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9

Stock News
·
Yesterday

Genfleet Therapeutics Files HKEX Next-Day Disclosure Return on Share Repurchase at HKD 26.14 Per Share

Reuters
·
Yesterday

GenFleet Therapeutics (GENFLEET-B) Buys Back 57,000 H-Shares, Treasury Position Doubles to 0.03% of Stock in Issue

Bulletin Express
·
Sep 08

Genfleet-B Completes Share Buyback Worth HK$1.54 Million

Stock News
·
Sep 08

Genfleet Therapeutics Files HKEX Next-Day Disclosure, Reports Share Repurchase at HKD 27.05

Reuters
·
Sep 08

Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B

Stock News
·
Sep 04

GenFleet Therapeutics Buys Back 20,000 H-Shares for HKD 0.55 Million, Lifting Treasury Stock to 59,000 Shares

Bulletin Express
·
Sep 03

GENFLEET-B Allocates HK$546,400 to Buy Back 20,000 Shares on September 3

Stock News
·
Sep 03

Genfleet Therapeutics Files HKEX Next-Day Return Disclosing Share Buyback at HKD 27.32

Reuters
·
Sep 03

GenFleet Reports Stable Share Base in August; Confirms 19.86% Public Float Compliance

Bulletin Express
·
Sep 02

GENFLEET-B Allocates HK$1.08 Million to Buy Back Shares on September 2nd

Stock News
·
Sep 02

Genfleet Therapeutics Files HKEX Next-Day Return Disclosing Share Buyback at HKD 27.6 Avg

Reuters
·
Sep 02

The Consensus EPS Estimates For GenFleet Therapeutics (Shanghai) Inc. (HKG:2595) Just Fell Dramatically

Simply Wall St.
·
Aug 27

GenFleet Therapeutics Lung Cancer Drug Candidate Enters Phase 2 Trial

MT Newswires Live
·
Aug 26

HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off

Stock News
·
Aug 26

GenFleet Pushes Lead KRAS G12D Candidate GFH375 into China Phase II First-Line NSCLC Trial, Testing Monotherapy and Combos with Cetuximab or Pemetrexed

Bulletin Express
·
Aug 26

Genfleet Therapeutics (Shanghai) - Gfh375 Enters Phase Ii Study for First-Line Kras G12d-Mutant Nsclc

THOMSON REUTERS
·
Aug 26

GenFleet Therapeutics (Shanghai) Reports Loss of Rmb220.17 Million for Six Months

Reuters
·
Aug 21

GenFleet 1H26 Net Loss Narrows 68.5% to RMB220 Million as Other Income Surges, Cash Pile at RMB1.78 Billion

Bulletin Express
·
Aug 21